Plante Moran Financial Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Plante Moran Financial Advisors, LLC

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$775.18 - $881.7 $2,325 - $2,645	3 New	3 $2,000
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $2,975 - $3,492	-5 Reduced 50.0%	5 $3,000
Q4 2021 Feb 09, 2022	SELL	$543.48 - $670.97 $64,674 - $79,845	-119 Reduced 92.25%	10 $6,000
Q3 2021 Nov 08, 2021	BUY	$574.03 - $680.96 $3,444 - $4,085	6 Added 4.88%	129 $78,000
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $8,510 - $10,053	18 Added 17.14%	123 $69,000
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $893 - $1,096	-2 Reduced 1.87%	105 $50,000
Q4 2020 Feb 09, 2021	BUY	$478.3 - $607.98 $51,178 - $65,053	107 New	107 $52,000
Q2 2020 Aug 10, 2020	SELL	$493.32 - $643.92 $98,664 - $128,783	-200 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $67,236 - $98,886	200 New	200 $98,000
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $20,011 - $27,485	-73 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $32,815 - $38,206	-120 Reduced 62.18%	73 $20,000
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $1,797 - $2,488	-6 Reduced 3.02%	193 $60,000
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $40,928 - $48,352	110 Added 123.6%	199 $82,000
Q4 2018 Jan 29, 2019	BUY	$335.82 - $403.04 $1,007 - $1,209	3 Added 3.49%	89 $33,000
Q3 2018 Nov 09, 2018	SELL	$351.14 - $408.51 $1,053 - $1,225	-3 Reduced 3.37%	86 $35,000
Q2 2018 Jul 26, 2018	SELL	$284.6 - $344.99 $1,707 - $2,069	-6 Reduced 6.32%	89 $31,000
Q1 2018 May 01, 2018	BUY	$315.82 - $393.78 $5,053 - $6,300	16 Added 20.25%	95 $33,000
Q3 2017 Nov 08, 2017	BUY	$431.38 - $504.0 $34,079 - $39,816	79	79 $35,000

1,488

85.7M

1.53M

1.44M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.